Satsuma Pharmaceuticals, Inc

(NASDAQ:STSA)

Latest On Satsuma Pharmaceuticals, Inc (STSA):

Date/Time Type Description Signal Details
2023-05-19 01:36 ESTNewsSatsuma migraine therapy accepted for FDA reviewN/A
2023-04-17 11:51 ESTNewsShin Nippon Biomedical agrees to acquire Satsuma Pharmaceuticals for $0.91 in cash per shareN/A
2023-03-29 03:27 ESTNewsSatsuma Pharmaceuticals GAAP EPS of -$0.70N/A
2022-11-16 01:31 ESTNewsSatsuma cut to neutral at Mizuho following migraine drug failureN/A
2022-11-14 15:38 ESTNewsSatsuma crashes 80% as migraine therapy STS101 fails phase 3 trialN/A
2022-11-04 08:50 ESTNewsSatsuma Pharmaceuticals GAAP EPS of -$0.48N/A
2022-10-10 17:31 ESTNewsSatsuma stock surges 11% after SVB upgrades on potential positive data for migraine therapy STS-101N/A
2022-09-20 22:38 ESTNewsSatsuma stock rises as migraine therapy STS101 shows safety in phase 3 trialN/A
2022-08-10 06:03 ESTNewsSatsuma Pharmaceuticals GAAP EPS of -$0.52N/A
2022-05-11 10:39 ESTNewsSatsuma Pharmaceuticals GAAP EPS of -$0.49 in-lineN/A
2022-03-16 12:27 ESTNewsSatsuma Pharmaceuticals GAAP EPS of -$0.49N/A
2021-11-09 17:33 ESTNewsSatsuma Pharmaceuticals EPS beats by $0.09N/A
2021-11-07 23:13 ESTNewsSatsuma Pharmaceuticals: Sizing Up This One Trick PonyN/A
2021-10-20 16:09 ESTNewsCommodore Capital buys $780K shares in Satsuma PharmaceuticalsN/A
2021-10-06 18:06 ESTNewsGDS, APP, OSMT and STSA among after hours moversN/A
2021-08-11 08:40 ESTNewsSatsuma Pharmaceuticals EPS beats by $0.03N/A
2021-07-29 05:24 ESTNewsSatsuma randomizes first subject in late-stage STS101 migraine studyN/A
2021-07-22 02:44 ESTNewsSatsuma shares surge on data from early-stage STS101 trialN/A
2021-07-22 02:44 ESTNewsSTSA, AXLA, CVAC and CRBP among after-hours moversN/A
2021-07-22 02:39 ESTNewsSatsuma upgraded at Mizuho; predicts late-stage trial successN/A
2021-04-05 15:31 ESTNewsFocus on equipment makers as Citi unveils positive catalyst watch; Invitae upgraded on Softbank investment and more in today’s analyst actionN/A
2021-03-25 21:29 ESTNewsSatsuma Pharmaceuticals EPS misses by $0.19N/A
2021-03-07 14:55 ESTNewsSatsuma: Launch Of 2nd Pivotal Trial For Migraine Med Ought To Cheer Share PriceN/A
2021-03-03 01:11 ESTAnalyst RatingThe Analyst Target Price has increased from $4.5 to $7.25.Buy
2021-03-02 00:30 ESTNewsSatsuma stock surges on migraine treatment development plan updateN/A
2021-03-02 00:29 ESTNewsSatsuma Pharmaceuticals announces private placement financingN/A
2020-11-26 21:41 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 05:23 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 05:23 ESTAnalyst RatingThe Analyst Target Price has decreased from $4.75 to $4.5.Neutral
2020-11-11 05:05 ESTEarnings EstimateAn EPS average of -$0.55 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-11 01:23 ESTNewsSatsuma Pharmaceuticals EPS beats by $0.02N/A
2020-11-08 00:59 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 17:14 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 14:08 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 05:10 ESTNewsSatsuma: Not All Over For Migraine Treatment Despite Trial FailureN/A
2020-09-23 10:06 ESTAnalyst RatingThe Analyst Target Price has decreased from $11.75 to $4.75.Neutral
2020-09-17 06:21 ESTFinancialsCompany financials have been released.Neutral
2020-09-14 21:18 ESTNewsSatsuma Migraine Failure, And Other News: The Good, Bad And Ugly Of BiopharmaN/A
2020-09-14 09:32 ESTAnalyst RatingThe Analyst Target Price has decreased from $26 to $11.75.Neutral
2020-09-11 11:40 ESTNewsSatsuma Pharma's STS101 flunks late-stage migraine study, shares down 84%N/A
2020-09-11 11:37 ESTNewsAnalysts bail on Satsuma Pharma after STS101 flopN/A
2020-09-11 09:34 ESTAnalyst RatingThe Analyst Target Price has decreased from $33.75 to $26.Neutral
2020-09-03 16:39 ESTInsider TradeThomas P. O'Neil has directly disposed of 750 shares and currently holds 0 shares.Sell
2020-09-03 16:39 ESTInsider TradeThomas P. O'Neil has directly acquired 750 shares and currently holds 750 shares.Buy
2020-09-03 16:39 ESTInsider TradeDETLEF ALBRECHT has directly acquired 1,000 shares and currently holds 21,212 shares.Buy
2020-09-03 16:39 ESTInsider TradeDETLEF ALBRECHT has directly disposed of 1,000 shares and currently holds 20,212 shares.Sell
2020-08-14 10:13 ESTAnalyst RatingThe Analyst Target Price has increased from $33.5 to $33.75.Buy
2020-08-14 10:13 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 05:46 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 01:30 ESTNewsSatsuma Pharmaceuticals reports Q2 resultsN/A

About Satsuma Pharmaceuticals, Inc (STSA):

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a novel therapeutic product for the acute treatment of migraine. Its lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in Phase III clinical trials and can be self-administered with a proprietary pre-filled, single-use, and nasal delivery device. The company was founded in 2016 and is headquartered in South San Francisco, California.

STSA Quotes by TradingView

See Advanced Chart

General

  • Name Satsuma Pharmaceuticals, Inc
  • Symbol STSA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 20
  • Fiscal Year EndDecember
  • IPO Date2019-09-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryRegional Banks
  • Web URLhttp://www.satsumarx.com
View More

Valuation

  • Trailing PE 2.21
  • Price/Book (Most Recent Quarter) 2.49
  • Enterprise Value EBITDA 0.1
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.50
  • Return on Assets -27%
  • Return on Equity -46%
  • Earnings Per Share -$11.81
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 203.16 million
  • EBITDA -12915000
  • Analyst Target Price $7.25
  • Book Value Per Share $7.03
View More

Share Statistics

  • Shares Outstanding 31.52 million
  • Shares Float 2.62 million
  • % Held by Insiders 1084%
  • % Held by Institutions 56.83%
  • Shares Short 692542
  • Shares Short Prior Month 652951
  • Short Ratio 1.45
  • Short % of Float 10%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • 52 Week High $36.11
  • 52 Week Low $3.5
  • 50 Day Moving Average 6.46
  • 200 Day Moving Average 5.94
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Satsuma Pharmaceuticals, Inc (STSA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Satsuma Pharmaceuticals, Inc (STSA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-10$N/A-$0.69-$0.735.48%
2020-06-302020-08-11$N/A-$0.65-$0.706.57%
2020-03-312020-05-12$N/A-$0.68-$0.67-1.49%
2019-12-312020-03-10$N/A-$0.62-$0.7921.52%
2019-09-302019-11-12$N/A-$2.26-$1.01-123.76%

Satsuma Pharmaceuticals, Inc (STSA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Satsuma Pharmaceuticals, Inc (STSA) Chart:

Satsuma Pharmaceuticals, Inc (STSA) News:

Below you will find a list of latest news for Satsuma Pharmaceuticals, Inc (STSA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Satsuma Pharmaceuticals, Inc (STSA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest STSA Trades:

Date Shares Price
Jun 13, 2022 6:33 PM EST200$3.1
Jun 13, 2022 6:33 PM EST200$3.1
Jun 13, 2022 6:33 PM EST100$3.1
Jun 13, 2022 7:00 PM EST2500$3.11
Jun 13, 2022 7:00 PM EST800$3.11

Satsuma Pharmaceuticals, Inc (STSA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2019-07-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692830/000000000019011376/0000000000-19-011376-index.htm
2019-08-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692830/000000000019012307/0000000000-19-012307-index.htm
2019-08-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1692830/000000000019012865/0000000000-19-012865-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023434/0000899243-19-023434-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023437/0000899243-19-023437-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023442/0000899243-19-023442-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023445/0000899243-19-023445-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023446/0000899243-19-023446-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023447/0000899243-19-023447-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023451/0000899243-19-023451-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023452/0000899243-19-023452-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023453/0000899243-19-023453-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023479/0000899243-19-023479-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023732/0000899243-19-023732-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023733/0000899243-19-023733-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000089924319023739/0000899243-19-023739-index.htm
2019-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000090221919000456/0000902219-19-000456-index.htm
2020-01-27SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000090221920000146/0000902219-20-000146-index.htm
2020-08-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000090221920000415/0000902219-20-000415-index.htm
2020-10-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000090221920000429/0000902219-20-000429-index.htm
2019-10-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000091957419006510/0000919574-19-006510-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000091957420001537/0000919574-20-001537-index.htm
2019-06-21DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692830/000095012319006096/0000950123-19-006096-index.htm
2019-08-02DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692830/000095012319006964/0000950123-19-006964-index.htm
2019-08-02DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1692830/000095012319006965/0000950123-19-006965-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000110465920021711/0001104659-20-021711-index.htm
2019-09-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000114420419044451/0001144204-19-044451-index.htm
2019-09-17SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1692830/000114420419044922/0001144204-19-044922-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000114420419044929/0001144204-19-044929-index.htm
2019-09-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000114420419045553/0001144204-19-045553-index.htm
2019-08-16S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692830/000119312519223576/0001193125-19-223576-index.htm
2019-08-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692830/000119312519223586/0001193125-19-223586-index.htm
2019-08-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692830/000119312519231142/0001193125-19-231142-index.htm
2019-09-03S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692830/000119312519235733/0001193125-19-235733-index.htm
2019-09-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692830/000119312519235737/0001193125-19-235737-index.htm
2019-09-108-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1692830/000119312519241950/0001193125-19-241950-index.htm
2019-09-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1692830/000119312519242128/0001193125-19-242128-index.htm
2019-09-11S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692830/000119312519243034/0001193125-19-243034-index.htm
2019-09-12S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1692830/000119312519244191/0001193125-19-244191-index.htm
2019-09-13424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1692830/000119312519244957/0001193125-19-244957-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692830/000119312519246858/0001193125-19-246858-index.htm
2019-09-17S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1692830/000119312519246952/0001193125-19-246952-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692830/000119312519289958/0001193125-19-289958-index.htm
2019-11-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000119312519302660/0001193125-19-302660-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692830/000119312520068760/0001193125-20-068760-index.htm
2020-03-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1692830/000119312520068880/0001193125-20-068880-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1692830/000119312520119086/0001193125-20-119086-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1692830/000119312520119097/0001193125-20-119097-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692830/000119312520140481/0001193125-20-140481-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692830/000119312520169520/0001193125-20-169520-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692830/000119312520188801/0001193125-20-188801-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692830/000119312520216295/0001193125-20-216295-index.htm
2020-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1692830/000119312520243159/0001193125-20-243159-index.htm
2020-10-23S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1692830/000119312520275551/0001193125-20-275551-index.htm
2019-09-11CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1692830/000135445719000443/0001354457-19-000443-index.htm
2019-09-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000138713119007014/0001387131-19-007014-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000138713119007016/0001387131-19-007016-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1692830/000138713120001540/0001387131-20-001540-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692830/000156459019042959/0001564590-19-042959-index.htm
2020-03-1010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1692830/000156459020009753/0001564590-20-009753-index.htm
2020-05-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692830/000156459020024703/0001564590-20-024703-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1692830/000156459020039324/0001564590-20-039324-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920005798/0001567619-20-005798-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920005799/0001567619-20-005799-index.htm
2020-03-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920005800/0001567619-20-005800-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/0001567619-20-006202-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920006203/0001567619-20-006203-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920007501/0001567619-20-007501-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920008036/0001567619-20-008036-index.htm
2020-05-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920009164/0001567619-20-009164-index.htm
2020-05-064/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920009165/0001567619-20-009165-index.htm
2020-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920009166/0001567619-20-009166-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/0001567619-20-010950-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/0001567619-20-011564-index.htm
2020-06-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920011565/0001567619-20-011565-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012247/0001567619-20-012247-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012248/0001567619-20-012248-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012249/0001567619-20-012249-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012250/0001567619-20-012250-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012251/0001567619-20-012251-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012252/0001567619-20-012252-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/0001567619-20-012533-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012688/0001567619-20-012688-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012995/0001567619-20-012995-index.htm
2020-07-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920012996/0001567619-20-012996-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/0001567619-20-014527-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/0001567619-20-016411-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000156761920016413/0001567619-20-016413-index.htm
2016-12-29DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000169283016000001/0001692830-16-000001-index.htm
2018-02-12D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1692830/000169283018000001/0001692830-18-000001-index.htm
2019-09-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1692830/999999999519002075/9999999995-19-002075-index.htm
2019-08-05SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1692830/999999999719006376/9999999997-19-006376-index.htm
2019-09-12SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1692830/999999999719006804/9999999997-19-006804-index.htm

Satsuma Pharmaceuticals, Inc (STSA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Satsuma Pharmaceuticals, Inc (STSA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1084%
Institutional Ownership: 5683%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-11Thomas P. O'NeilChief Financial OfficerSell1,000.0027.6827,678.000.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/0001567619-20-006202-index.htm
2020-05-20Thomas P. O'NeilChief Financial OfficerSell2,000.0025.0050,000.000.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/0001567619-20-010950-index.htm
2020-06-01Thomas P. O'NeilChief Financial OfficerSell1,000.0025.3225,323.500.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/0001567619-20-011564-index.htm
2020-06-23Thomas P. O'NeilChief Financial OfficerSell2,115.0035.2374,511.870.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/0001567619-20-012533-index.htm
2020-07-01Thomas P. O'NeilChief Financial OfficerSell300.0025.637,690.200.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-01Thomas P. O'NeilChief Financial OfficerSell394.0026.7010,520.080.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-01Thomas P. O'NeilChief Financial OfficerSell306.0027.598,443.640.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-08-05Thomas P. O'NeilChief Financial OfficerSell1,000.0025.0025,000.000.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/0001567619-20-014527-index.htm
2020-09-01Thomas P. O'NeilChief Financial OfficerSell750.0022.1916,644.530.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/0001567619-20-016411-index.htm
2020-03-11Thomas P. O'NeilChief Financial OfficerBuy1,000.004.564,560.001,000.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920006202/0001567619-20-006202-index.htm
2020-06-01Thomas P. O'NeilChief Financial OfficerBuy1,000.004.564,560.001,000.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920011564/0001567619-20-011564-index.htm
2020-08-05Thomas P. O'NeilChief Financial OfficerBuy1,000.004.564,560.001,000.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920014527/0001567619-20-014527-index.htm
2019-09-17KEN TAKANASHIDirectorBuy233,333.0015.003,499,995.001,561,719.00https://www.sec.gov/Archives/edgar/data/1692830/000089924319023732/0000899243-19-023732-index.htm
2019-09-17TPG Group Holdings (SBS) Advisors, Inc.10% Share HolderBuy100,000.0015.001,500,000.001,885,939.00https://www.sec.gov/Archives/edgar/data/1692830/000138713119007016/0001387131-19-007016-index.htm
2020-05-20Thomas P. O'NeilChief Financial OfficerBuy2,000.004.569,120.002,000.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920010950/0001567619-20-010950-index.htm
2020-04-01DETLEF ALBRECHTChief Medical OfficerSell200.0020.254,049.0020,012.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920007501/0001567619-20-007501-index.htm
2020-04-14DETLEF ALBRECHTChief Medical OfficerSell800.0020.0016,000.0020,012.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920008036/0001567619-20-008036-index.htm
2020-03-11DETLEF ALBRECHTChief Medical OfficerSell1,000.0027.4227,422.4020,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920006203/0001567619-20-006203-index.htm
2020-05-05DETLEF ALBRECHTChief Medical OfficerSell1,000.0020.0020,000.0020,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920009166/0001567619-20-009166-index.htm
2020-06-01DETLEF ALBRECHTChief Medical OfficerSell1,000.0025.2625,256.9020,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920011565/0001567619-20-011565-index.htm
2020-07-01DETLEF ALBRECHTChief Medical OfficerSell300.0025.697,707.3320,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-07-01DETLEF ALBRECHTChief Medical OfficerSell600.0026.9916,194.7220,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-07-01DETLEF ALBRECHTChief Medical OfficerSell100.0027.812,781.0020,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-08-03DETLEF ALBRECHTChief Medical OfficerSell800.0022.8518,281.6020,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-08-03DETLEF ALBRECHTChief Medical OfficerSell200.0023.124,624.0220,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-09-01DETLEF ALBRECHTChief Medical OfficerSell1,000.0022.2122,210.0020,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920016413/0001567619-20-016413-index.htm
2020-07-01DETLEF ALBRECHTChief Medical OfficerBuy100.004.56456.0020,312.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-04-01DETLEF ALBRECHTChief Medical OfficerBuy200.004.56912.0020,412.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920007501/0001567619-20-007501-index.htm
2020-08-03DETLEF ALBRECHTChief Medical OfficerBuy200.004.56912.0020,412.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-07-01DETLEF ALBRECHTChief Medical OfficerBuy300.004.561,368.0020,512.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-04-14DETLEF ALBRECHTChief Medical OfficerBuy800.004.563,648.0020,812.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920008036/0001567619-20-008036-index.htm
2020-07-01DETLEF ALBRECHTChief Medical OfficerBuy600.004.562,736.0020,812.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012818/0001567619-20-012818-index.htm
2020-08-03DETLEF ALBRECHTChief Medical OfficerBuy800.004.563,648.0021,012.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920014306/0001567619-20-014306-index.htm
2020-06-23Thomas P. O'NeilChief Financial OfficerBuy2,115.001.042,199.602,115.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012533/0001567619-20-012533-index.htm
2020-03-11DETLEF ALBRECHTChief Medical OfficerBuy1,000.004.564,560.0021,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920006203/0001567619-20-006203-index.htm
2020-05-05DETLEF ALBRECHTChief Medical OfficerBuy1,000.004.564,560.0021,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920009166/0001567619-20-009166-index.htm
2020-06-01DETLEF ALBRECHTChief Medical OfficerBuy1,000.004.564,560.0021,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920011565/0001567619-20-011565-index.htm
2020-09-01DETLEF ALBRECHTChief Medical OfficerBuy1,000.004.564,560.0021,212.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920016413/0001567619-20-016413-index.htm
2020-07-01Thomas P. O'NeilChief Financial OfficerBuy300.004.561,368.00300.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-01Thomas P. O'NeilChief Financial OfficerBuy306.004.561,395.36306.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2020-07-01Thomas P. O'NeilChief Financial OfficerBuy394.004.561,796.64394.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920012820/0001567619-20-012820-index.htm
2019-09-17Rajeev M. ShahDirectorBuy1,140,946.0015.0017,114,190.004,489,471.00https://www.sec.gov/Archives/edgar/data/1692830/000089924319023733/0000899243-19-023733-index.htm
2019-09-17RA CAPITAL MANAGEMENT, LLCDirectorBuy1,333,333.0015.0019,999,995.004,681,858.00https://www.sec.gov/Archives/edgar/data/1692830/000114420419044929/0001144204-19-044929-index.htm
2019-09-17Rajeev M. ShahDirectorBuy192,387.0015.002,885,805.004,681,858.00https://www.sec.gov/Archives/edgar/data/1692830/000089924319023733/0000899243-19-023733-index.htm
2020-09-01Thomas P. O'NeilChief Financial OfficerBuy750.004.563,420.00750.00https://www.sec.gov/Archives/edgar/data/1692830/000156761920016411/0001567619-20-016411-index.htm